Navigation Links
Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial

iled from time to time in Geron's periodic reports, including the quarterly report on Form 10-Q for the quarter ended March 31, 2007.

Contact

Geron Corporation
David L. Greenwood, 650-473-7765
Chief Financial Officer
info@geron.com
or
Russo Partners, LLC
David Schull, 858-717-2310 (Media)
david.schull@russopartnersllc.com
Matthew Haines, 212-845-4235 (Investors)
matthew.haines@russopartnersllc.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
2. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
3. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
4. Telomerase Presentations at the AACR 2007 Annual Meeting
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
7. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
8. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
9. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
10. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
11. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO

Post Your Comments:
(Date:11/25/2009)...RNewswire/-- ChemoCentryx,Inc.,announcedtodaythat...heProspectiveRandomizedOralTherapyEvaluationinCroh...ntswithmoderate-to-severeCrohn,sdiseasedemonstrate...typrofile.Thestudydemonstratedevidenceofclinicalef...0-pointdecreaseintheCrohn,sDiseaseActivityIndex(CD...
(Date:11/24/2009)...re-FirstCall/--QuestDiagnosticsIncorporated(NYSE: ...,informationandservices,announcedthatitisscheduled...enceinNewYorkCity.ThepresentationisscheduledforWed...Duringtheconference,thecompanywillreaffirmits2009g...cometoexceed18%ofrevenues,anddilutedearningspersha...
(Date:11/24/2009)...e/--Inadditiontofamily,friendsandhealth,cancersurv...anksgivinggratitudelist. ,, "Theyheardthefactsa...Monday,sverdictstotaling$103millionindamagesagains...womennationwidewhohavesuedWyethandPfizerpharmaceut...mpro.Wisneskiandtheothervictimsofhormonetherapyhav...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2The Symphony Guild Announces Artist Lineup for 2009 Event 58899 1The Symphony Guild Announces Artist Lineup for 2009 Event 58899 2The Symphony Guild Announces Artist Lineup for 2009 Event 58899 3YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 1YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 2YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 3YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 4YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 5YM BIOSCIENCES ANNOUNCES OFFER FOR CYTOPIA LTD AN AUSTRALIAN CANCER FOCUSED DEVELOPMENT COMPANY 14357 6New Hampshire Rx Card Launching Statewide 5239 1New Hampshire Rx Card Launching Statewide 5239 2
... Median Overall Survival vs. Interferon-Alpha, CO... division of Wyeth (NYSE: WYE ), announced today ...TM) (temsirolimus) for the,first-line treatment of...,who have at least three of six prognostic risk fa... that specifically inhibits the mTOR (mammalian,ta...
...ew Study Site at Leading Urban Medical Center Will... Bavituximab HCV/HIV Co-Infection ...l Investigator of The Johns Hopkins Study Site, ... Patients--, TUSTIN, Calif., Nov. 26 Peregrine,P...stage biopharmaceutical,company developing monoclo...
Other Medicine Technology:Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 2Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 3Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 4Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 5Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 6Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV 2Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV 3Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV 4
(Date:11/25/2009)...exibility,AllowingCompanytoAccessCapitalatitsDiscr...Call/-LabopharmInc.(TSX:DDS;NASDAQ: DDSS )todayann...reement(SEDA)withYAGlobalMasterSPVLtd.,afundmanage...nt,YAhascommittedtoprovideupto$25millionofcapitald...oughthepurchaseofnewlyissuedLabopharmcommonshares....
(Date:11/25/2009)...e have come together to form the International Cli...health professionals across the world to help tack...ouncil will be officially launched on Wednesday 25... being published by the Lancet on the public hea...emissions, ahead of the UN Climate Change Conferen...
(Date:11/25/2009)...se may make a case for population-wide reduction, ...lthDay News) -- It,s known that eating a lot of sa...ure. Now there,s confirmation of a corollary: High...ter risk of cardiovascular disease and stroke. ,...n of BMJ found that a difference of just 5 grams...
(Date:11/25/2009)...e/--IntroducingPariBeautyProfessionalArtistry,acom...edicatedtoprovidingprestigeformulasatirresistiblep...ndcolorcosmeticbrandtolaunchunderMakeupArtistrySto...iscoandToronto,wasfoundedandismanagedbyaseasonedte...erienceintheindustry.PariBeautywillhaveasignifican...
(Date:11/25/2009)...oday through Sunday, November 29th, PlushBeds.com ...tex sofa bed mattress + an additional 10% site-wid...ey back guarantee. Use the code “BLACKFRIDAY...this special offer. , (PR...ll travel from Thanksgiving through the New Year t...
Breaking Medicine News(10 mins):Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 2Health News:Labopharm Enters Into CAD$25 Million Standby Equity Distribution Agreement 3Health News:Senior doctors launch global movement to tackle climate change 2Health News:Pari Beauty Professional Artistry 2Health News:Providing Comfort for Holiday Guests Just Got Easier 2Health News:Providing Comfort for Holiday Guests Just Got Easier 3
... trust hospital in London has devised a new plan b...r kind affectionate demeanor by gifting them with ...ate chip cookies as an incentive every time a head...ng patients revealed that many patients were aghas...
...gnosis of breast cancer has taken on a new meaning...host of new therapies and detection techniques, si...en who have been fighting the disease. To build on... to reduce the total incidence of the disease. One...
... infection of the deadly H5N1 strain of the bird f...in Egypt, the official news// agency MENA reported... infection was discovered in Luxor, some 680 km so...man Shahin. The area has been quarantined an...
...rs here have surgically removed female reproductiv...tence// for rape. "Along with male reproduct... removed them. Both these organs have been sent fo...3 such cases have been found in the world," said A...
...e of other side of the grass is greener; the west ... whereas, in China, home grown remedies //are bein.... Recently a proposal is doing the rounds to...also piqued the government. TCM departments i...
..., which has twice the level of malnutrition compar...n school lunch meals to boost the health// of ana...ing to the Canada-based NGO Micronutrient Initiati...g it with high level of iron and reshaping it in t...
Other Medicine News:Health News:A treat for nurses who chip in with tender loving care! 2Health News:Novel Vaccine Shows Promise against Early Stage Breast Cancer 2Health News:Iron rich rice to beat anaemia in children 2
Right Dr. White Carina Hook
...ivery., ,Designed for adolescent and adult popula... lumen and injection port for rapid drug delivery ...eal tubes designs which allow for CO2 monitoring, ... additional adaptors., ETCO2™ Uncuffed endot...
SHERIDAN LTS Endotracheal Tubes
SPIRAL-FLEX® Oral Precut Reinforced Tubes
Medicine Products: